{
  "papers": [
    {"pmid": "37363821", "title": "A multi-society Delphi consensus statement on new fatty liver disease nomenclature", "journal": "Hepatology", "year": 2023, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 2},
    {"pmid": "33271056", "title": "FIB-4 first strategy for primary care identification of advanced fibrosis", "journal": "Hepatology", "year": 2021, "retraction_status": "none", "pubpeer_comment_count": 1, "letter_to_editor_count": 0},
    {"pmid": "31430416", "title": "Age-adjusted FIB-4 thresholds in elderly", "journal": "J Hepatol", "year": 2020, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 1},
    {"pmid": "17326139", "title": "Validation of FIB-4 in chronic liver disease", "journal": "Hepatology", "year": 2007, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "32492532", "title": "Diagnostic accuracy of VCTE for advanced fibrosis", "journal": "J Hepatol", "year": 2020, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 1},
    {"pmid": "32492533", "title": "VCTE in Asian population", "journal": "Liver Int", "year": 2020, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "29222917", "title": "Liver biopsy: gold standard or imperfect reference?", "journal": "Gut", "year": 2018, "retraction_status": "none", "pubpeer_comment_count": 2, "letter_to_editor_count": 3},
    {"pmid": "25865049", "title": "Lifestyle intervention 7-10% weight loss NASH resolution", "journal": "Gastroenterology", "year": 2015, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "27322798", "title": "Pioglitazone in NASH: long-term outcomes", "journal": "Ann Intern Med", "year": 2016, "retraction_status": "correction", "pubpeer_comment_count": 1, "letter_to_editor_count": 2},
    {"pmid": "20218622", "title": "Vitamin E vs placebo in NASH (PIVENS)", "journal": "NEJM", "year": 2010, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 5},
    {"pmid": "33185364", "title": "Semaglutide in NASH phase 2", "journal": "NEJM", "year": 2021, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 1},
    {"pmid": "33340572", "title": "Longitudinal NIT trajectory in NAFLD", "journal": "Hepatology", "year": 2021, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "29624699", "title": "HCC surveillance in cirrhosis: cost-effectiveness", "journal": "J Hepatol", "year": 2018, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 1},
    {"pmid": "32178492", "title": "FAST score for at-risk NASH", "journal": "Lancet GH", "year": 2020, "retraction_status": "expression_of_concern", "pubpeer_comment_count": 3, "letter_to_editor_count": 1},
    {"pmid": "32294530", "title": "MAST score derivation and validation", "journal": "J Hepatol", "year": 2021, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "32294531", "title": "MRI-PDFF for steatosis quantification", "journal": "J Hepatol", "year": 2021, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "27568284", "title": "MRE thresholds for fibrosis staging", "journal": "Radiology", "year": 2017, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "27649089", "title": "ELF test in primary care NAFLD pathway", "journal": "Lancet GH", "year": 2017, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "33002420", "title": "MEFIB index validation", "journal": "Hepatology", "year": 2021, "retraction_status": "none", "pubpeer_comment_count": 1, "letter_to_editor_count": 0},
    {"pmid": "28714183", "title": "NAFLD epidemiology global burden", "journal": "Hepatology", "year": 2018, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "31430417", "title": "Bariatric surgery in NAFLD Asian", "journal": "JAMA Surg", "year": 2020, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "28986335", "title": "CAP cutoffs for steatosis grading meta-analysis", "journal": "Hepatology", "year": 2018, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "38324483", "title": "Resmetirom phase 3 MAESTRO-NASH", "journal": "NEJM", "year": 2024, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 4},
    {"pmid": "37195353", "title": "Pegozafermin phase 2b ENLIVEN", "journal": "NEJM", "year": 2023, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 1},
    {"pmid": "37195355", "title": "Efruxifermin phase 2b HARMONY", "journal": "Lancet", "year": 2023, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 1},
    {"pmid": "38028023", "title": "Tirzepatide MASH histology phase 2", "journal": "NEJM", "year": 2023, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 1},
    {"pmid": "38924754", "title": "Survodutide MASH phase 2 readout", "journal": "NEJM", "year": 2024, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "39501010", "title": "Korean cohort FIB-4 elderly threshold", "journal": "Clin Mol Hepatol", "year": 2025, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "39501011", "title": "LSM 15 kPa rule-in revisited multi-cohort", "journal": "J Hepatol", "year": 2025, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "39501012", "title": "Resmetirom NIT monitoring 6-month outcomes", "journal": "Hepatology", "year": 2025, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0},
    {"pmid": "39501013", "title": "Retatrutide MASH phase 2", "journal": "NEJM", "year": 2025, "retraction_status": "none", "pubpeer_comment_count": 0, "letter_to_editor_count": 0}
  ]
}